Literature DB >> 21254290

Do people regard cheaper medicines effective? Population survey on public opinion of generic substitution in Finland.

Reeta Heikkilä1, Pekka Mäntyselkä, Riitta Ahonen.   

Abstract

PURPOSE: Generic substitution (GS) is an important way to decrease medical costs. We aimed to study the opinions and attitudes of Finnish people about GS five years after it was introduced, the reasons for substituting and what people think about generic medicines.
METHODS: We sent a postal survey to a random stratified population sample of 3000 Finnish people aged at least 18 years in 2008. The random sample was drawn from five mainland counties. The sampling was conducted by the Finnish Population Register Centre. The response rate was 62% (n=1844) after exclusion of unobtainable addressees (n=34).
RESULTS: Most of the respondents (70.9%) considered GS a good law reform. However, there were many respondents who were unsure about their opinion (26.9%). The respondents also held the opinion that cheaper medicines are effective (80.9%) and that GS does not cause any risk to drug safety (84.9%). Most of the respondents (88.4%) who had substituted their medicines had not noticed any difference between the previously used and substituted medicines. Two main reasons for substituting were a desire to save money and recommendation by pharmacists. Of the respondents, 16.3% had experience with both substituting and refusing it. The percentage of the respondents who only had experience with refusing GS was 8.6%. Female gender, older age and use of prescription drugs were associated with refusing.
CONCLUSIONS: Finnish people consider GS a good reform. They also have confidence in the effect of cheaper medicines. Savings are the main reason for accepting GS.
Copyright © 2010 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21254290     DOI: 10.1002/pds.2084

Source DB:  PubMed          Journal:  Pharmacoepidemiol Drug Saf        ISSN: 1053-8569            Impact factor:   2.890


  25 in total

1.  INN or brand name drug prescriptions: a multilevel, cross-sectional study in general practice.

Authors:  Florent De Bruyne; Arnaud Ponçon; Joris Giai; Xavier Dode; David Darmon; Cyrille Colin; François Gueyffier; Laurent Letrilliart
Journal:  Eur J Clin Pharmacol       Date:  2018-10-27       Impact factor: 2.953

2.  Patient perceptions of generic medicines: a mixed-methods study.

Authors:  Suzanne Dunne; Bill Shannon; Colum Dunne; Walter Cullen
Journal:  Patient       Date:  2014       Impact factor: 3.883

3.  The association between automatic generic substitution and treatment persistence with oral bisphosphonates.

Authors:  O Ström; E Landfeldt
Journal:  Osteoporos Int       Date:  2011-11-26       Impact factor: 4.507

4.  Consumers' perception of generic substitution in Iran.

Authors:  Nazila Yousefi; Gholamhossein Mehralian; Farzad Peiravian; Samaneh NourMohammadi
Journal:  Int J Clin Pharm       Date:  2015-02-20

5.  Patients' knowledge and attitude towards therapeutic reference pricing system in Slovenia.

Authors:  Nika Marđetko; Mitja Kos
Journal:  Int J Clin Pharm       Date:  2016-08-08

Review 6.  What Do Users of Generic Medicines Think of Them? A Systematic Review of Consumers' and Patients' Perceptions of, and Experiences with, Generic Medicines.

Authors:  Suzanne S Dunne
Journal:  Patient       Date:  2016-12       Impact factor: 3.883

7.  Associations between generic substitution and patients' attitudes, beliefs and experiences.

Authors:  Jette Rathe; Pia Larsen; Morten Andersen; Maja Paulsen; Dorte Jarbøl; Janus Thomsen; Jens Soendergaard
Journal:  Eur J Clin Pharmacol       Date:  2013-06-14       Impact factor: 2.953

8.  Price, familiarity, and availability determine the choice of drug - a population-based survey five years after generic substitution was introduced in Finland.

Authors:  Pekka Mäntyselkä; Riitta Ahonen; Reeta Heikkilä
Journal:  BMC Clin Pharmacol       Date:  2011-12-15

Review 9.  A review of the differences and similarities between generic drugs and their originator counterparts, including economic benefits associated with usage of generic medicines, using Ireland as a case study.

Authors:  Suzanne Dunne; Bill Shannon; Colum Dunne; Walter Cullen
Journal:  BMC Pharmacol Toxicol       Date:  2013-01-05       Impact factor: 2.483

Review 10.  What do people really think of generic medicines? A systematic review and critical appraisal of literature on stakeholder perceptions of generic drugs.

Authors:  Suzanne S Dunne; Colum P Dunne
Journal:  BMC Med       Date:  2015-07-29       Impact factor: 8.775

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.